YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
8.15
-0.23 (-2.74%)
Mar 6, 2026, 4:00 PM EST - Market closed
YD Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | 0.51 | 0.35 | 0.36 |
| Revenue Growth (YoY) | 45.76% | -3.84% | - |
| Cost of Revenue | 0.36 | 0.2 | 0.23 |
| Gross Profit | 0.16 | 0.15 | 0.13 |
| Selling, General & Admin | 1.13 | 0.16 | 0.18 |
| Research & Development | 0.49 | - | - |
| Operating Expenses | 1.62 | 0.16 | 0.18 |
| Operating Income | -1.46 | -0.01 | -0.04 |
| Interest Expense | -0 | -0 | -0 |
| Interest & Investment Income | 0.01 | 0 | 0 |
| Other Non Operating Income (Expenses) | 0.06 | 0.03 | 0.06 |
| EBT Excluding Unusual Items | -1.39 | 0.02 | 0.01 |
| Gain (Loss) on Sale of Investments | - | - | -0.06 |
| Pretax Income | -1.39 | 0.02 | -0.05 |
| Income Tax Expense | 0.03 | 0 | 0 |
| Net Income | -1.41 | 0.01 | -0.05 |
| Net Income to Common | -1.41 | 0.01 | -0.05 |
| Shares Outstanding (Basic) | 1 | 1 | - |
| Shares Outstanding (Diluted) | 1 | 1 | - |
| Shares Change (YoY) | 4.01% | - | - |
| EPS (Basic) | -1.29 | 0.01 | - |
| EPS (Diluted) | -1.29 | 0.01 | - |
| Free Cash Flow | -1.91 | -0.06 | 0.07 |
| Free Cash Flow Per Share | -1.75 | -0.05 | - |
| Gross Margin | 30.44% | 43.82% | 36.58% |
| Operating Margin | -286.45% | -2.81% | -12.33% |
| Profit Margin | -276.58% | 3.87% | -13.95% |
| Free Cash Flow Margin | -374.58% | -15.98% | 19.21% |
| EBITDA | -1.36 | -0.01 | -0.04 |
| EBITDA Margin | -265.93% | -2.11% | -11.34% |
| D&A For EBITDA | 0.1 | 0 | 0 |
| EBIT | -1.46 | -0.01 | -0.04 |
| EBIT Margin | -286.45% | -2.81% | -12.33% |
| Effective Tax Rate | - | 23.17% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.